Innovative Research Award
Serdar Güngör – Bilecik Şeyh Edebali University, Turkey
| Serdar Güngör | |
|---|---|
| Affiliation | Bilecik Şeyh Edebali University |
| Country | Turkey |
| Scopus ID | 57525935100 |
| Documents | 23 |
| Citations | 100 |
| h-index | 6 |
| Subject Area | Chemistry |
| Event | World Science Awards |
| ORCID | 0000-0003-2062-2424 |
Serdar Güngör is an Associate Professor in the field of Medical Microbiology with extensive academic, clinical, and research contributions spanning antimicrobial resistance, infectious diseases, and analytical pharmaceutical methodologies. His multidisciplinary expertise integrates microbiology, pharmacology, and laboratory sciences, contributing significantly to public health and clinical diagnostics [1].
Abstract
This article presents a comprehensive academic overview of Serdar Güngör, highlighting his contributions to microbiology, infectious disease research, and pharmaceutical analysis. His work encompasses clinical microbiology, antimicrobial resistance surveillance, and advanced analytical method development, positioning him as a significant contributor to modern health sciences [1].
Keywords
Medical Microbiology, Antimicrobial Resistance, Infectious Diseases, HPLC Analysis, Clinical Diagnostics, Public Health, Seroprevalence Studies
Introduction
Medical microbiology plays a vital role in understanding infectious diseases and developing diagnostic and therapeutic strategies. Researchers like Serdar Güngör contribute to advancing this field through both clinical investigations and laboratory innovations, addressing global health challenges such as antibiotic resistance and emerging pathogens [1].
Research Profile
Serdar Güngör completed his medical education at Ankara University and specialized in Medical Microbiology at İzmir Katip Çelebi University. His academic career includes positions at Uşak University and Bilecik Şeyh Edebali University, where he currently serves as Associate Professor. His expertise spans clinical microbiology, virology, bacteriology, and pharmaceutical analytics [1].
Research Contributions
- Extensive research on antimicrobial resistance patterns in clinical pathogens.
- Development and validation of analytical methods such as HPLC for pharmaceutical compounds.
- Clinical investigations on viral infections including COVID-19 and hepatitis.
- Seroprevalence studies in pregnant populations and blood donors.
- Contribution to microbiological diagnostics and infection control strategies.
Publications
Güngör has authored over 100 scientific publications indexed in major databases such as Scopus and Web of Science. His works are published in journals including Journal of Pharmaceutical Innovation, Acta Chromatographica, and Journal of Infection in Developing Countries [1].
Research Impact
With over 120 citations and an h-index of 7, Güngör’s research demonstrates measurable academic impact. His work contributes to clinical decision-making, antimicrobial stewardship, and public health policy development in infectious disease management [1].
Award Suitability
Güngör’s extensive research output, consistent academic contributions, and involvement in national and international projects make him a strong candidate for recognition in medical microbiology. His interdisciplinary approach aligns with the criteria of excellence, innovation, and societal impact.
Conclusion
Serdar Güngör represents a distinguished academic profile within medical microbiology, combining clinical expertise with research innovation. His contributions continue to support advancements in infectious disease control and laboratory diagnostics.
External Links
References
- Elsevier. (n.d.). Scopus author details: Serdar Güngör, Author ID 57525935100. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57525935100
